ColonBroom sells a supplement called GLP-1 Booster. This page does two things with it: it records what the company states about the product, with the date each statement was read, and it sets that beside the indexed human literature on the fibre the brand is built on.
It reaches no verdict, and it carries no score. That is the method our GLP-1 booster category page established for this cluster, and the reason for it is that a verdict on a finished supplement requires a trial of that supplement, which is exactly what could not be located here.
What the seller states
Read from colonbroom.com on 2026-09-21.
| Where | What it says |
|---|---|
| Homepage product tile | "GLP-1 Booster (12.3k reviews)" · "Effective weight loss" · "Appetite control supplement" · "Natural GLP-1 booster" |
| Page title element | "Gut Health Supplements & GLP-1 Booster | Colonbroom" |
| Homepage section | "Clinically tested and proven"; "In a recent 10-week clinical trial, participants experienced significant improvements in weight loss, digestion, energy, and appetite control" |
| Homepage footnote | "All scientific research and evidence can be found here" |
| Homepage footer | "The statements on this site have not been evaluated by the FDA. Our products are not intended to diagnose, treat, cure, or prevent any disease and do not replace medical advice." |
| Site text bundle, /ingredients | "The main component, psyllium husk, is a type of fiber that works as a gentle, bulk-forming laxative"; "Psyllium's unique gel can help slow the absorption of sugars and fats after meals" |
The last two rows come from the localisation text bundle embedded in the ingredients and research pages, which is retrievable even though the rendered pages are not. A string in a bundle is not proof of where it is displayed, and it is quoted here as the company's own wording rather than as a description of any particular page.
Two of these sit oddly together. "Clinically tested and proven" and "not intended to diagnose, treat, cure, or prevent any disease" are on the same page, a few hundred pixels apart. Both are ordinary in the supplement trade — the second is the disclaimer the Dietary Supplement Health and Education Act requires alongside a structure-function claim — but a reader who takes the first at face value has been told something the second withdraws.
The product that has no product page
The most checkable thing about this product is how little of it is published.
The company's own sitemap at colonbroom.com/sitemap.xml listed 63 URLs across seven locale sets on 2026-09-21 — about-us, contact, ingredients, plans, research, reviews, store-locator and terms, repeated for the US, German, French, British, Italian, Dutch and Swedish storefronts. Not one product page appears in it. The obvious address, colonbroom.com/products/glp-1-booster, returned HTTP 404 the same day.
A product tile advertising 12,300 reviews, and no indexed page for the product. This is the pattern our patch brands page documented in the neighbouring market: the merchandise moves faster than the documentation, and the parts of the site a search engine can see are the parts that are not the product. The mechanism is a quiz-to-plan funnel rather than a catalogue, so the shopper reaches the product through a questionnaire rather than through a page with a panel on it. The commercial logic is clear. The consequence for a reader is that the ingredient list is not where a reader would look for it.
The one place the company sets the product against an alternative is its own comparison table, and it is worth reading carefully. In the embedded text bundle the column of drawbacks is headed "Just GLP-1 Booster" and the column of benefits "With Colostrum + Fiber". That table is an upsell rather than an assessment, but it is the seller's own published comparison, and in it the booster used on its own is the weaker option.
The literature on the ingredient the brand is built on
The company describes psyllium husk as "the main component". Whether it is a component of this particular product is not established — the panel was not readable — so what follows is about the brand's principal fibre, not about the booster's formula.
A PubMed search for psyllium AND GLP-1 on 2026-09-21 returns nine records. That is the whole indexed literature connecting the two terms. Of the nine: one 2026 molecular review of viscous fibres and the incretin axis, one study in diabetic rats, two in mice, one in dogs, one general review of soluble fibre and glycaemic response, one retrospective analysis of Google search trends, and two human randomised crossover studies that actually measured GLP-1 in people.
Those two are the whole human record, and they run in the opposite direction from the product name.
Frost 2003 gave ten subjects pasta meals in a two-by-two crossover, with or without 1.7 g of psyllium — the amount tied to the US health claim for soluble fibre — and with or without added fat. The psyllium-enriched pasta "had no significant effect on gastric emptying or the incremental area under the curve (IAUC) for GLP-1, insulin or glucose compared with the control pasta".
Karhunen 2010 went far higher, to 23.0 g of psyllium across two of five isoenergetic test meals in sixteen volunteers. Its reported GLP-1 result was a fall, not a rise: "postprandial GLP-1 concentration was significantly suppressed after a fiber- and protein-rich meal, in contrast to the initial increases following the other meals."
The control that makes the first result a finding
A null result is only worth reporting if the experiment could have detected a positive one, and Frost 2003 carries its own proof that it could. In the same subjects, on the same days, with the same assay, adding 30 g of sunflower oil and 3 g of sodium propionate to the meal "significantly increased the IAUC for GLP-1 (P<0.001)" and delayed gastric emptying.
So the study registered a GLP-1 increase when the meal produced one. It did not register one for psyllium at that dose. That is a stronger statement than "no effect was found", and it is the kind of check this site now runs in both directions as a matter of routine.
What this page does not establish
It does not establish what the GLP-1 Booster contains, because the ingredient panel was not readable from the seller's pages on 2026-09-21. It does not establish that the ten-week trial referred to on the homepage does not exist — only that it could not be located from the company's own public documents, which is a different claim and a weaker one.
Nine indexed records is a small literature, and a title-and-abstract search is not a systematic review; a study could exist that neither search term reaches. Two human studies finding no increase is evidence that the effect is not large and easy to find, not proof that it is absent.
And it does not assess the product. There is no score here, no rating, no ranking and no recommendation, for or against. Whether any supplement is appropriate for a particular person, especially alongside a prescribed medicine, is a decision for that person and a clinician, and our editorial standards explain why we leave it there.
Sources and dates
- colonbroom.com homepage, sitemap,
/ingredientsand/research— retrieved 2026-09-21. The rendered ingredient and research pages returned no readable text to an automated request; the quotations above come from the localisation text bundle embedded in the same responses. - Frost GS, Brynes AE, Dhillo WS, Bloom SR, McBurney MI. "The effects of fiber enrichment of pasta and fat content on gastric emptying, GLP-1, glucose, and insulin responses to a meal." Eur J Clin Nutr 2003 Feb;57(2):293-8. PMID 12571662, doi:10.1038/sj.ejcn.1601520.
- Karhunen LJ, Juvonen KR, Flander SM, et al. "A psyllium fiber-enriched meal strongly attenuates postprandial gastrointestinal peptide release in healthy young adults." J Nutr 2010 Apr;140(4):737-44. PMID 20147463, doi:10.3945/jn.109.115436.
- PubMed E-utilities search
psyllium AND GLP-1, run 2026-09-21, 9 records; each record's abstract opened.